TAEGTMEYER, A. B.; LEUPPI, J.; KULLAK-UBLICK, G. Roflumilast – a phosphodiesterase-4 inhibitor licensed for add-on therapy in severe COPD. Swiss Medical Weekly, [S. l.], v. 142, n. 2930, p. w13628, 2012. DOI: 10.4414/smw.2012.13628. Disponível em: https://smw.ch/index.php/smw/article/view/1535. Acesso em: 28 mar. 2024.